# Polaryx Therapeutics, Inc.: Form 8-K, filed Jul 17, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: 8-K
- Filed: 2026-07-17
- Accepted by EDGAR: Jul 17, 2026, 08:00 ET
- Period: 2026-07-16
- Accession: 0001213900-26-078912
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026078912/ea0298274-8k_polaryx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026078912/

## Items reported

- Item 5.08: Item not in the standard list
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026078912/ea0298274-8k_polaryx.htm

Filed Jul 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-078912. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.